Research and analysis

Bladder Anticholinergics: review of risk of dementia

Public Assessment Report on the safety review of the available data on the risk of dementia with the use of bladder anticholinergic medicines.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 27 July 2026

Documents

Bladder Anticholinergics and dementia: Public Assessment Report (PAR)

PDF, 891 KB, 94 pages

This file may not be suitable for users of assistive technology.

Request an accessible format

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This report presents the MHRA’s review of safety data on the risk of dementia with the use of bladder anticholinergic medicines.

Published 27 July 2026